Lazebnik LB - Search Results

Year	Number of Results
1966	1
1968	1
1969	1
1970	1
1971	1
1985	1
1986	1
1987	1
1988	1
1989	4
1990	6
1991	4
1992	5
1993	2
1994	1
1995	2
1996	3
1997	1
1998	2
2000	2
2002	9
2003	8
2004	10
2005	8
2006	10
2007	18
2008	14
2009	18
2010	25
2011	41
2012	18
2013	18
2014	11
2015	9
2016	6
2020	1
2022	1
2024	0

1

Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review.

Aghemo A, Alekseeva OP, Angelico F, Bakulin IG, Bakulina NV, Bordin D, Bueverov AO, Drapkina OM, Gillessen A, Kagarmanova EM, Korochanskaya NV, Kucheryavii UA, Lazebnik LB, Livzan MA, Maev IV, Martynov AI, Osipenko MF, Sas EI, Starodubova A, Uspensky YP, Vinnitskaya EV, Yakovenko EP, Yakovlev AA. Aghemo A, et al. Among authors: lazebnik lb. Ann Med. 2022 Dec;54(1):1548-1560. doi: 10.1080/07853890.2022.2069854. Ann Med. 2022. PMID: 35635048 Free PMC article. Review.

2

[Prevention of complications of colonic diverticular disease in outpatient practice].

Levchenko SV, Komissarenko IA, Lazebnik LB. Levchenko SV, et al. Among authors: lazebnik lb. Ter Arkh. 2016;88(1):96-100. doi: 10.17116/terarkh201688196-100. Ter Arkh. 2016. PMID: 27014782 Review. Russian.

3

[Cardiovascular pathology associated with digestive system diseases].

Lazebnik LB, Komissarenko IA, Mikheeva OM. Lazebnik LB, et al. Eksp Klin Gastroenterol. 2011;(5):69-74. Eksp Klin Gastroenterol. 2011. PMID: 21919242 Review. Russian.

4

THE INCIDENCE OF PRIMARY AND SECONDARY RESISTANCE TO THE ANTI-CYTOKINE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.

Lazebnik LB, Sagynbaeva VE. Lazebnik LB, et al. Eksp Klin Gastroenterol. 2016 Jul;12(12):30-34. Eksp Klin Gastroenterol. 2016. PMID: 29889419 Review. English, Russian.

5

[Epidemiology of gastroduodenal ulcer].

Lazebnik LB, Guseĭnzade MG, Li IA, Efremov LI. Lazebnik LB, et al. Ter Arkh. 2007;79(2):12-5. Ter Arkh. 2007. PMID: 17460960 Russian. No abstract available.

6

[Cancer prevention in gastroenterology].

Lazebnik LB, Khomeriki SG. Lazebnik LB, et al. Eksp Klin Gastroenterol. 2012;(5):3-13. Eksp Klin Gastroenterol. 2012. PMID: 23402165 Russian.

7

[Realities and prospects for the use of cell technologies for the treatment of chronic diffuse liver diseases].

Lazebnik LB, Golovanova EV, Slupskaia VA, Trubitsina IE, Kniazev OV, Shaposhnikova NA. Lazebnik LB, et al. Eksp Klin Gastroenterol. 2011;(6):3-10. Eksp Klin Gastroenterol. 2011. PMID: 22168071 Review. Russian.

8

[Non-invasive techniques in diagnosis of steatosis and fibrosis in nonalcoholic fatty liver disease].

Roĭtberg GE, Lazebnik LB, Zvenigorodskaia LA, Sharkhun OO, Ushakova TI, Platonova OE. Roĭtberg GE, et al. Among authors: lazebnik lb. Eksp Klin Gastroenterol. 2013;(7):3-9. Eksp Klin Gastroenterol. 2013. PMID: 24772867 Clinical Trial. Russian.

9

[Quantitative and qualitative evalution of polymorbidity in geriatric practice].

Lazebnik LB, Konev IuV, Efremov LI. Lazebnik LB, et al. Eksp Klin Gastroenterol. 2013;(9):3-8. Eksp Klin Gastroenterol. 2013. PMID: 24933957 Russian. No abstract available.

10

LOOKING INTO THE FUTURE OF DIGESTIVE HEALTH.

Lazebnik LB, Stefanyuk OV. Lazebnik LB, et al. Eksp Klin Gastroenterol. 2015;(5):51-7. Eksp Klin Gastroenterol. 2015. PMID: 26387171 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

265 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

265 results

Results by year